Alzheimer’s disease

By Gazzaley Adam   Small Scott A.  

Network: Computation in Neural Systems, Vol. 22, Iss. 1-4, 2011-03 ,pp. : 173-185

Informa Healthcare

Access to resources Recommend Favorite

F₂-Isoprostanes as Biomarkers of Late-onset Alzheimer’s Disease

By Montine Thomas   Quinn Joseph   Kaye Jeffrey   Morrow Jason  

Journal of Molecular Neuroscience, Vol. 33, Iss. 1, 2007-09 ,pp. : 114-119

Humana Press, Inc

Access to resources Recommend Favorite

GAB2 is not associated with late-onset Alzheimer’s disease in Chinese Han

By Lin Kangguang   Tang Muni   Han Haiying   Guo Yangbo   Lin Yuhua   Ma Cui  

Neurological Sciences, Vol. 31, Iss. 3, 2010-06 ,pp. : 277-281

Springer Publishing Company

Access to resources Recommend Favorite

Platelet phospholipase A₂ activity in Alzheimer’s disease and mild cognitive impairment

By Gattaz W. F.   Forlenza O. V.   Talib L. L.   Barbosa N. R.   Bottino C. M. C.  

Journal of Neural Transmission, Vol. 111, Iss. 5, 2004-05 ,pp. : 591-601

Springer Publishing Company

Access to resources Recommend Favorite

Identification of GAB2 as a risk factor for late-onset Alzheimer’s disease

By  

Future Neurology, Vol. 2, Iss. 4, 2007-07 ,pp. : 357-359

Future Medicine

Access to resources Recommend Favorite